There is a range of evaluation studies underway to learn more about how non-surgical devices can be used for adult male circumcision. This map from AVAC illustrates enrolling, ongoing or recently completed VMMC (VMMC) device evaluations as of 2013.
VMMC (VMMC) Device Evaluations
The HIV Prevention Research-to-Rollout Continuum
AVAC Playbook 2013–2014: Global goals and priorities
The AVAC’s Playbook is a concise look at global goals related to ten areas that are critical to ending the AIDS epidemic. The squares contain long-term goals; in the circles we have laid out priorities for 2014. Working with our partners, we develop and implement advocacy strategies to get us closer to these goals.
ARV-Based Prevention Pipeline (December 2013)
AIDS Vaccine Research: An overview (2013)
Use of Injectable Contraceptives and HIV Acquisition: The data to-date
Planned PrEP Demonstration Projects in Resource-Poor Settings
Clinical Trial Evidence for Oral and Topical Tenofovir-Based Prevention
ARV-Based Prevention Research and Development Product Pipeline: A Research Timeline
This timeline shows efficacy trials, related confirmatory studies and dates of possible regulatory submission for a range of ARV-based prevention options.
The Tipping Point
One way to measure progress in fighting AIDS is to compare the number of new HIV infections with the increase in HIV positive people on antiretroviral therapy (ART) over a given time period. An AIDS epidemic reaches its “tipping point” when the number of annual new HIV infection falls below the annual increase in patients starting ART. Coverage matters. A first milestone is treating approximately two thirds of people in need in a given country. Once that level is reached, countries and advocates can track progress to the tipping point.